CHANGE IS THE CURE Trademark

Trademark Overview

On Friday, July 30, 2021, a trademark application was filed for CHANGE IS THE CURE with the United States Patent and Trademark Office. The USPTO has given the CHANGE IS THE CURE trademark a serial number of 90857961. The federal status of this trademark filing is REGISTERED as of Tuesday, August 29, 2023. This trademark is owned by BeiGene, Ltd.. The CHANGE IS THE CURE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical treatment of cancer; Medical treatment of lupus erythematosus and rheumatoid arthritis; providing medical information; providing information in the fields of health, medicine, pharmaceuticals and the pharmaceutical industry; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Pharmaceutical compounding services, namely, chemical processing and production of medicines and pharmaceuticals that are customized for a specific patient for the treatment of cancer and rheumatoid arthritis, treatment of cancer, autoimmune and inflammatory diseases and infectious diseases
change is the cure

General Information

Serial Number90857961
Word MarkCHANGE IS THE CURE
Filing DateFriday, July 30, 2021
Status700 - REGISTERED
Status DateTuesday, August 29, 2023
Registration Number7151735
Registration DateTuesday, August 29, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2022

Trademark Statements

Goods and ServicesMedical treatment of cancer; Medical treatment of lupus erythematosus and rheumatoid arthritis; providing medical information; providing information in the fields of health, medicine, pharmaceuticals and the pharmaceutical industry; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Pharmaceutical compounding services, namely, chemical processing and production of medicines and pharmaceuticals that are customized for a specific patient for the treatment of cancer and rheumatoid arthritis, treatment of cancer, autoimmune and inflammatory diseases and infectious diseases

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 27, 2021
Primary Code044
First Use Anywhere DateSunday, May 1, 2022
First Use In Commerce DateSunday, May 1, 2022

Trademark Owner History

Party NameBeiGene, Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSan Mateo, CA 94404
Party NameBeiGene, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSan Mateo, CA 94404
Party NameBeiGene, Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGrand Cayman KY1-1108
KY

Trademark Events

Event DateEvent Description
Wednesday, March 27, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 27, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 27, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 29, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 29, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, July 27, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, July 26, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 17, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 17, 2023NON-FINAL ACTION E-MAILED
Monday, April 17, 2023SU - NON-FINAL ACTION - WRITTEN
Tuesday, March 14, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, February 27, 2023USE AMENDMENT FILED
Tuesday, March 14, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 27, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, February 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 30, 2023SOU EXTENSION 1 GRANTED
Monday, January 30, 2023SOU EXTENSION 1 FILED
Monday, January 30, 2023SOU TEAS EXTENSION RECEIVED
Thursday, December 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 6, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 12, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 22, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 7, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 6, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 6, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 30, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 30, 2022NON-FINAL ACTION E-MAILED
Monday, May 30, 2022NON-FINAL ACTION WRITTEN
Thursday, April 28, 2022ASSIGNED TO EXAMINER
Tuesday, April 19, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 18, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 23, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 23, 2022NON-FINAL ACTION E-MAILED
Wednesday, March 23, 2022NON-FINAL ACTION WRITTEN
Tuesday, March 22, 2022ASSIGNED TO EXAMINER
Monday, September 27, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 3, 2021NEW APPLICATION ENTERED

Related Keywords

cure change treatment pharmaceuticals medical information providing cancer pharmaceutical rheumatoid diseases arthritis